These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 31128406)
1. Concentration of microtubule associated protein tau (MAPT) in urine and saliva as a potential biomarker of traumatic brain injury in relationship with blood-brain barrier disruption in postmortem examination. Olczak M; Poniatowski ŁA; Niderla-Bielińska J; Kwiatkowska M; Chutorański D; Tarka S; Wierzba-Bobrowicz T Forensic Sci Int; 2019 Aug; 301():28-36. PubMed ID: 31128406 [TBL] [Abstract][Full Text] [Related]
2. Tau protein (MAPT) as a possible biochemical marker of traumatic brain injury in postmortem examination. Olczak M; Niderla-Bielińska J; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T Forensic Sci Int; 2017 Nov; 280():1-7. PubMed ID: 28942078 [TBL] [Abstract][Full Text] [Related]
3. Post-mortem detection of neuronal and astroglial biochemical markers in serum and urine for diagnostics of traumatic brain injury. Olczak M; Poniatowski ŁA; Siwińska A; Kwiatkowska M Int J Legal Med; 2023 Sep; 137(5):1441-1452. PubMed ID: 37272985 [TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of dynein, dynactin, and kinesin in the cerebral tissue as a possible supplemental diagnostic tool for traumatic brain injury in postmortem examination. Olczak M; Poniatowski Ł; Kwiatkowska M; Samojłowicz D; Tarka S; Wierzba-Bobrowicz T Folia Neuropathol; 2019; 57(1):51-62. PubMed ID: 31038188 [TBL] [Abstract][Full Text] [Related]
5. Brain-originated peptides as possible biochemical markers of traumatic brain injury in cerebrospinal fluid post-mortem examination. Olczak M; Kwiatkowska M; Niderla-Bielińska J; Chutorański D; Tarka S; Wierzba-Bobrowicz T Folia Neuropathol; 2018; 56(2):97-103. PubMed ID: 30509029 [TBL] [Abstract][Full Text] [Related]
6. Elevated serum and urine levels of progranulin (PGRN) as a predictor of microglia activation in the early phase of traumatic brain injury: a further link with the development of neurodegenerative diseases. Olczak M; Poniatowski ŁA; Siwińska A; Kwiatkowska M; Chutorański D; Wierzba-Bobrowicz T Folia Neuropathol; 2021; 59(1):81-90. PubMed ID: 33969679 [TBL] [Abstract][Full Text] [Related]
7. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury? Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249 [TBL] [Abstract][Full Text] [Related]
8. Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids. Ondruschka B; Sieber M; Kirsten H; Franke H; Dreßler J J Neurotrauma; 2018 Sep; 35(17):2044-2055. PubMed ID: 29732941 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the risk of traumatic brain injury and evaluation neurogranin and myelin basic protein as potential biomarkers of traumatic brain injury in postmortem examination. Shang Y; Wang Y; Guo Y; Ren L; Zhang X; Wang S; Zhang C; Cai J Forensic Sci Med Pathol; 2022 Sep; 18(3):288-298. PubMed ID: 35201602 [TBL] [Abstract][Full Text] [Related]
10. Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury. Bohnert S; Wirth C; Schmitz W; Trella S; Monoranu CM; Ondruschka B; Bohnert M Int J Legal Med; 2021 Jul; 135(4):1525-1535. PubMed ID: 33895854 [TBL] [Abstract][Full Text] [Related]
11. Role of Caspase-3-Mediated Apoptosis in Chronic Caspase-3-Cleaved Tau Accumulation and Blood-Brain Barrier Damage in the Corpus Callosum after Traumatic Brain Injury in Rats. Glushakova OY; Glushakov AO; Borlongan CV; Valadka AB; Hayes RL; Glushakov AV J Neurotrauma; 2018 Jan; 35(1):157-173. PubMed ID: 28637381 [TBL] [Abstract][Full Text] [Related]
12. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. Gabbita SP; Scheff SW; Menard RM; Roberts K; Fugaccia I; Zemlan FP J Neurotrauma; 2005 Jan; 22(1):83-94. PubMed ID: 15665604 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of MAPT enhances the effect of bexarotene and attenuates the damage after traumatic brain injury using in vivo and in vitro experiments. Dong H; Wang H; Wang L Folia Neuropathol; 2020; 58(3):253-264. PubMed ID: 33099295 [TBL] [Abstract][Full Text] [Related]
14. A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury. Pandey S; Singh K; Sharma V; Pandey D; Jha RP; Rai SK; Chauhan RS; Singh R Br J Neurosurg; 2017 Jun; 31(3):356-363. PubMed ID: 28293977 [TBL] [Abstract][Full Text] [Related]
16. Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery. Kokiko-Cochran ON; Saber M; Puntambekar S; Bemiller SM; Katsumoto A; Lee YS; Bhaskar K; Ransohoff RM; Lamb BT J Neurotrauma; 2018 Jan; 35(1):73-84. PubMed ID: 28859549 [TBL] [Abstract][Full Text] [Related]
17. TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination. Bohnert S; Seiffert A; Trella S; Bohnert M; Distel L; Ondruschka B; Monoranu CM Int J Legal Med; 2020 Nov; 134(6):2167-2176. PubMed ID: 32719959 [TBL] [Abstract][Full Text] [Related]
18. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation. Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311 [TBL] [Abstract][Full Text] [Related]